You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-grade serous epithelial ovarian cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platinum-resistant Ovarian Cancer Trial in China (IN10018 in combination with PLD)

Recruiting
  • Platinum-resistant Ovarian Cancer
  • IN10018 in combination with PLD
  • Anyang, China
  • +6 more
Sep 20, 2022

Early Detection of High Grade Serous Epithelial Ovarian Cancer

Active, not recruiting
  • Epithelial Ovarian Cancer
  • DNA Methylation
  • Dallas, Texas
    Baylor University Medical Center
Jan 31, 2022

High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

Not yet recruiting
  • High Grade Serous Ovarian Cancer (HGSOC)
  • FAPI PET CT
  • (no location specified)
Jul 20, 2023

High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)

Recruiting
  • High Grade Serous Carcinoma
  • +2 more
  • Toronto, Ontario, Canada
  • +2 more
Nov 28, 2022

New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

Enrolling by invitation
  • Ovarian Cancer
  • +2 more
  • CRS scoring
  • Routine blood laboratory testing before treatment
  • Guangzhou, Guangdong, China
    The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Nov 2, 2023

Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

Not yet recruiting
  • Ovarian Cancer
  • +6 more
  • (no location specified)
Oct 27, 2022

Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary, High Grade Endometrioid Ovarian Cancer Trial in Guangzhou (Fluzoparib

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Cetntre
Sep 25, 2023

Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer Trial in Pierre-Bénite

Recruiting
  • Adult Patients With Platinum-sensitive, Relapsed, High Grade Serous Epithelial Ovarian Cancer
  • Pharmacokinetics, Dosage of Niraparib
  • Pierre-Bénite, France
    Hôpital Lyon sud, Institut de Cancérologie des Hospices Civils d
Apr 19, 2022

High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

Not yet recruiting
  • High Grade Serous Ovarian Cancer
  • Blood sample and tissue sample
  • Montpellier, France
    NOUGARET Stephanie
Oct 10, 2023

Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jul 18, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +17 more
  • Biopsy
  • +3 more
  • Augusta, Georgia
  • +4 more
Jan 25, 2023

Ovarian Cancer Trial in Kelowna, Vancouver, Kingston (Durvalumab, BA3011, BA3021)

Recruiting
  • Ovarian Cancer
  • Kelowna, British Columbia, Canada
  • +4 more
Nov 14, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Chromosomal Instability in Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • +7 more
  • Testing for chromosomal instability (CIN)
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

CINSARC Genomic Signature as Predictor of Resectability of

Completed
  • Ovarian Adenocarcinoma
  • CINSARC signature
  • Toulouse, France
    Institut Claudius Regaud Institut Universitaire du cancer Toulou
Dec 22, 2022

Ovarian Cancer, High Grade Ovarian Serous Trial in New York (PET/MRI, Contrast enhanced CT)

Active, not recruiting
  • Ovarian Cancer
  • High Grade Ovarian Serous
  • PET/MRI
  • Contrast enhanced CT
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Mar 2, 2022

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

Active, not recruiting
  • BRCA1 Mutation
  • +4 more
  • Talazoparib Oral Capsule
  • Providence, Rhode Island
  • +1 more
Nov 30, 2022

miRNAs in High Grade Serous Ovarian Cancer

Recruiting
  • High Grade Serous Ovarian Cancer
    • Bologna, Bo, Italy
      IRCCS- Azienda Ospedaliera-Universitaria di Bologna
    Dec 3, 2021

    Pembrolizumab and Anlotinib in Treatment of High-Grade Serous

    Completed
    • High-Grade Serous Ovarian Cancer
    • Pembrolizumab combined Anlotinib
    • Qingdao, Shandong, China
      Xiaochun Zhang
    Dec 26, 2021

    Gynecologic Cancer, Ovarian Cancer, High Grade Serous Carcinoma Trial in Ljubljana (Carboplatin)

    Recruiting
    • Gynecologic Cancer
    • +3 more
    • Ljubljana, Slovenia
    • +1 more
    Aug 6, 2022

    Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

    Recruiting
    • Advanced Fallopian Tube Carcinoma
    • +21 more
    • Biopsy
    • +2 more
    • Bethesda, Maryland
    • +2 more
    Jan 25, 2023

    Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

    Completed
    • Ovarian Cancer
    • Manchester, United Kingdom
      The Christie NHS Foundation Trust
    Feb 4, 2022

    Hyperthermic Intraperitoneal Chemo, Neoadjuvant Chemo Trial in Guangzhou (HIPEC, intravenous chemo)

    Recruiting
    • Hyperthermic Intraperitoneal Chemotherapy
    • Neoadjuvant Chemotherapy
    • HIPEC
    • intravenous chemotherapy
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen Memorial Hospital
    Feb 17, 2022

    High-grade Serous Ovarian Cancer Trial in Belgium, Spain, United Kingdom (APR-246, Pegylated Liposomal Doxorubicin Hydrochloride

    Completed
    Has Results
    • High-grade Serous Ovarian Cancer
    • APR-246
    • Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
    • Gent, Belgium
    • +11 more
    Jul 19, 2022